Status:
COMPLETED
Improving Effective Contraceptive Use Among Opioid-maintained Women
Lead Sponsor:
University of Vermont
Conditions:
Contraceptive Usage
Opioid Dependence
Eligibility:
FEMALE
18-44 years
Phase:
PHASE1
Brief Summary
Nearly 9 of every 10 pregnant opioid-dependent women report that the current pregnancy was unintended and the majority of non-pregnant opioid-maintained women do not use contraception or use less effe...
Detailed Description
The rate of unintended pregnancy among opioid-dependent women is extremely high: nearly 9 of every 10 pregnant opioid-dependent women report that the current pregnancy was unintended, a rate 2-3 times...
Eligibility Criteria
Inclusion
- 18-44 years of age
- pre-menopausal and have no history of a tubal ligation or hysterectomy
- have had heterosexual vaginal sex in the past 12 months
- have no plans to become pregnant in the next 6 months
- be medically eligible to use prescription contraceptives
- report no prescription contraceptive method use (i.e., no use of pills, patch, ring in the past 7 days or depot injections, implants, or IUD in the past 3 months) OR report primary use of a non-prescription method (i.e., condoms, sponge, diaphragm, withdrawal, or rhythm method)
- have been in opioid maintenance treatment for at least the past 30 days
- be English-speaking.
Exclusion
- failure to meet the aforementioned inclusion criteria
- refusal to participate
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT01425060
Start Date
October 1 2011
End Date
June 1 2014
Last Update
March 17 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Vermont Substance Abuse Treatment Center
Burlington, Vermont, United States, 05401